Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (Q92182863)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 July 2019

Language	Label	Description	Also known as
English	Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network	scientific article published on 23 July 2019

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

12

object named as

Guy Boivin

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Shelly A McNeil

23

object named as

Shelly A McNeil

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Melissa K Andrew

11

object named as

Melissa K Andrew

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

18

object named as

Allison McGeer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Rachel Karen Green

14

object named as

Karen Green

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

6

object named as

Todd F Hatchette

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

16

object named as

Mark Loeb

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

22

object named as

Duncan Webster

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

5

object named as

Ardith Ambrose

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Jennie Johnstone

15

object named as

Jennie Johnstone

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

2

object named as

May ElSherif

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Jason J LeBlanc

1

object named as

Jason J LeBlanc

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Donna MacKinnon-Cameron

4

object named as

Donna MacKinnon-Cameron

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Hayley D Gillis

8

object named as

Hayley D Gillis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

10

object named as

Walter Demczuk

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

author name string

Lingyun Ye

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Amanda L S Lang

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Irene Martin

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

William Bowie

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Anne E McCarthy

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Makeda Semret

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Sylvie Trottier

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Louis Valiquette

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

publication date

23 July 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

5466-5473

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Pneumococcal Capsules and Their Types: Past, Present, and Future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary‐Area Streptococcus pneumoniae Research (CASPER) Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

The burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Detection and prediction of Streptococcus pneumoniae serotypes directly from nasopharyngeal swabs using PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants' vaccination?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Serotype 3 Remains the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2012-2014) Despite Continued Reductions in Other 13-Valent Conjugate Vaccine Serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

PCV13 serotype decrease in Italian adolescents and adults in the post-PCV13 era: Herd protection from children or secular trend?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Pneumococcal Community-Acquired Pneumonia Detected by Serotype-Specific Urinary Antigen Detection Assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Commentary on paradoxical observations pertaining to the impact of the 13-valent pneumococcal conjugate vaccine on serotype 3 Streptococcus pneumoniae infections in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Pneumococcal Disease and the Effectiveness of the PPV23 Vaccine in Adults: A Two-Stage Bayesian Meta-Analysis of Observational and RCT Reports

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.05.003

7 January 2021

Identifiers

10.1016/J.VACCINE.2019.05.003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31345638%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q92182863&oldid=1775327894"